These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


355 related items for PubMed ID: 26992255

  • 1. In vitro Synergistic Activity of Caspofungin Plus Polymyxin B Against Fluconazole-Resistant Candida glabrata.
    Adams EK, Ashcraft DS, Pankey GA.
    Am J Med Sci; 2016 Mar; 351(3):265-70. PubMed ID: 26992255
    [Abstract] [Full Text] [Related]

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 3. Time-kill assay and Etest evaluation for synergy with polymyxin B and fluconazole against Candida glabrata.
    Pankey G, Ashcraft D, Kahn H, Ismail A.
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5795-800. PubMed ID: 25049251
    [Abstract] [Full Text] [Related]

  • 4. In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Oliveira ER, Fothergill AW, Kirkpatrick WR, Coco BJ, Patterson TF, Redding SW.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3544-5. PubMed ID: 16048980
    [Abstract] [Full Text] [Related]

  • 5. Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
    Chen TC, Chen YH, Chen YC, Lu PL.
    Kaohsiung J Med Sci; 2012 Jun; 28(6):306-15. PubMed ID: 22632885
    [Abstract] [Full Text] [Related]

  • 6. Synergistic activities of three triazoles with caspofungin against Candida glabrata isolates determined by time-kill, Etest, and disk diffusion methods.
    Kiraz N, Dag I, Yamac M, Kiremitci A, Kasifoglu N, Oz Y.
    Antimicrob Agents Chemother; 2010 May; 54(5):2244-7. PubMed ID: 20194697
    [Abstract] [Full Text] [Related]

  • 7. Activity of Combined Antifungal Agents Against Multidrug-Resistant Candida glabrata Strains.
    Denardi LB, Keller JT, Oliveira V, Mario DAN, Santurio JM, Alves SH.
    Mycopathologia; 2017 Oct; 182(9-10):819-828. PubMed ID: 28493006
    [Abstract] [Full Text] [Related]

  • 8. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA, Denardi LB, Bandeira LA, Antunes MS, Santurio JM, Severo LC, Alves SH.
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [Abstract] [Full Text] [Related]

  • 9. In vitro synergistic antifungal activities of caspofungin in combination with fluconazole or voriconazole against Candida species determined by the Etest method.
    Yang Q, Liu Z, Wang Y, Xie J, Zhang K, Dong Y, Wang YF.
    Int J Infect Dis; 2022 Sep; 122():982-990. PubMed ID: 35907476
    [Abstract] [Full Text] [Related]

  • 10. [In vitro activity of caspofungin against fluconazole-resistant Candida isolates from patients with HIV infection].
    Ortiz de la Tabla-Ducasse V, Masiá-Canuto M, Martín-González C, Gutiérrez-Rodero F.
    Enferm Infecc Microbiol Clin; 2004 Sep; 22(6):328-31. PubMed ID: 15228899
    [Abstract] [Full Text] [Related]

  • 11. In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates.
    Hooper RW, Ashcraft DS, Pankey GA.
    Med Mycol; 2019 Jan 01; 57(1):122-126. PubMed ID: 29618039
    [Abstract] [Full Text] [Related]

  • 12. Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient.
    Krogh-Madsen M, Arendrup MC, Heslet L, Knudsen JD.
    Clin Infect Dis; 2006 Apr 01; 42(7):938-44. PubMed ID: 16511756
    [Abstract] [Full Text] [Related]

  • 13. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B, Sanguinetti M, Fiori B, La Sorda M, Spanu T, Sanglard D, Fadda G.
    J Antimicrob Chemother; 2006 Aug 01; 58(2):458-61. PubMed ID: 16757500
    [Abstract] [Full Text] [Related]

  • 14. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA, Diekema DJ, Boyken L, Tendolkar S, Hollis RJ, Pfaller MA.
    J Clin Microbiol; 2006 Feb 01; 44(2):324-6. PubMed ID: 16455878
    [Abstract] [Full Text] [Related]

  • 15. Antifungal drug susceptibility, molecular basis of resistance to echinocandins and molecular epidemiology of fluconazole resistance among clinical Candida glabrata isolates in Kuwait.
    Al-Baqsami ZF, Ahmad S, Khan Z.
    Sci Rep; 2020 Apr 10; 10(1):6238. PubMed ID: 32277126
    [Abstract] [Full Text] [Related]

  • 16. Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.
    Shields RK, Nguyen MH, Press EG, Updike CL, Clancy CJ.
    Antimicrob Agents Chemother; 2013 Aug 10; 57(8):3528-35. PubMed ID: 23669387
    [Abstract] [Full Text] [Related]

  • 17. Assessment of the in vitro kinetic activity of caspofungin against Candida glabrata.
    Nagappan V, Boikov D, Vazquez JA.
    Antimicrob Agents Chemother; 2010 Jan 10; 54(1):522-5. PubMed ID: 19841143
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Candida spp. as determined by CLSI broth microdilution method.
    Pfaller MA, Hata K, Jones RN, Messer SA, Moet GJ, Castanheira M.
    Diagn Microbiol Infect Dis; 2011 Oct 10; 71(2):167-70. PubMed ID: 21696907
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of aminocandin and caspofungin against Candida glabrata including isolates with reduced caspofungin susceptibility.
    Brzankalski GE, Najvar LK, Wiederhold NP, Bocanegra R, Fothergill AW, Rinaldi MG, Pattterson TF, Graybill JR.
    J Antimicrob Chemother; 2008 Nov 10; 62(5):1094-100. PubMed ID: 18658194
    [Abstract] [Full Text] [Related]

  • 20. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oliveira ER, Fothergill A, Kirkpatrick WR, Patterson TF, Redding SW.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr 10; 105(4):457-9. PubMed ID: 18329581
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.